CYSTINE DEPLETION BY WR-1065 IN CYSTINOTIC CELLS - MECHANISM OF ACTION

被引：12

作者：

BUTLER, JD

GAHL, WA

TIETZE, F

机构：

[1] NIADDKD,CTR CLIN,INTERINST GENET PROGRAM,BETHESDA,MD 20205

[2] NIH,INTERMEDIARY METAB SECT,BETHESDA,MD 20205

来源：

BIOCHEMICAL PHARMACOLOGY | 1985年 / 34卷 / 12期

关键词：

D O I：

10.1016/0006-2952(85)90415-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2179 / 2185

页数：7

共 22 条

[1] PROTECTION OF CULTURED MAMMALIAN-CELLS BY S-2-(3-AMINOPROPYLAMINO)ETHYLPHOSPHOROTHIOIC ACID(WR-2721) [J].

ANTOKU, S .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (10) :1481-1485

[2] THIOL-DISULFIDE INTERCHANGE BETWEEN CYSTINE AND N-2-MERCAPTOETHYL-1,3-DIAMINOPROPANE AS A POTENTIAL TREATMENT FOR CYSTINURIA [J].

BLACKBURN, P ;

PETERSON, CM .

ANALYTICAL BIOCHEMISTRY, 1984, 136 (01) :31-38

[3] PANTETHINE DEPLETES CYSTINOTIC FIBROBLASTS OF CYSTINE [J].

BUTLER, JD ;

ZATZ, M .

JOURNAL OF PEDIATRICS, 1983, 102 (05) :796-798

[4] PANTETHINE AND CYSTAMINE DEPLETE CYSTINE FROM CYSTINOTIC FIBROBLASTS VIA EFFLUX OF CYSTEAMINE-CYSTEINE MIXED DISULFIDE [J].

BUTLER, JD ;

ZATZ, M .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (02) :411-416

[5] ADVERSE REACTIONS TO ORAL CYSTEAMINE USE IN NEPHROPATHIC CYSTINOSIS [J].

CORDEN, BJ ;

SCHULMAN, JD ;

SCHNEIDER, JA ;

THOENE, JG .

DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1981, 3 (01) :25-30

[6]

ERICKSON B, 1967, ACTA CHEM SCAND, V21, P1304

[7] CHARACTERISTICS OF CYSTINE COUNTER-TRANSPORT IN NORMAL AND CYSTINOTIC LYSOSOME-RICH LEUKOCYTE GRANULAR FRACTIONS [J].

GAHL, WA ;

TIETZE, F ;

BASHAN, N ;

BERNARDINI, I ;

RAIFORD, D ;

SCHULMAN, JD .

BIOCHEMICAL JOURNAL, 1983, 216 (02) :393-400

[8]

GAHL WA, 1982, J BIOL CHEM, V257, P9570

[9] DIAMINE OXIDASE ACTIVITY IN FIBROBLASTS FROM NORMAL AND CYSTIC-FIBROSIS PATIENTS [J].

GAHL, WA ;

PITOT, HC .

PEDIATRIC RESEARCH, 1980, 14 (02) :118-121

[10]

KLIGERMAN MM, 1980, CANCER CLIN TRIALS, V3, P217

← 1 2 3 →